InvestorsHub Logo

TOB

Followers 162
Posts 5764
Boards Moderated 1
Alias Born 09/15/2010

TOB

Re: sox040713 post# 74971

Friday, 10/24/2014 10:09:02 AM

Friday, October 24, 2014 10:09:02 AM

Post# of 402805
Excellent analysis soc040713. CTIX is definitely flying below the radar. Which is a good thing as it gave us early retail buyers the chance to get in at prices that I believe will seem cheap once CTIX uplists and institutional buying starts in earnest.

The little guy and the early investors usually get killed in these early stage bio-techs. Not the case with CTIX!

CTIX is an unusual diamond in the rough. Here we are at an enviable share price and share structure, poised for an ever greater rally to higher share prices. Well funded by Aspire Capital, the Gold Standard of bio-tech financing, with minimal dilution, and with three drugs either in clinical trials or soon to enter.

And yes, CTIX has completed Phase 2b clinical trial for a new class of antibiotics. Phase 3 is coming!

Data suggests Brilacidin may also be the new 'best in class' with a one day dosing vs 7 days for the current best in class. And amazingly, science showing Brilacidin does not succumb to resistance. Boom!

This baby bio-tech is a sleeping giant. Yes a top performer for 2014, but IMO we ain't seen nothing yet.

I pose the question: What will happen when $10 -$30 million wants to buy CTIX shares? That is peanuts for the market.


"Games are won by players who focus on the playing field -- not by those whose eyes are glued to the scoreboard." - Warren Buffett

Volume:
Day Range:
Bid:
Ask:
Last Trade Time:
Total Trades:
  • 1D
  • 1M
  • 3M
  • 6M
  • 1Y
  • 5Y
Recent IPIX News